Advertisement
Advertisement

TheBody.com/TheBodyPRO.com covers The 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)

HAART May Not Be Enough to Normalize Immune Aging in Women, Study Finds

A Poster Spotlight From CROI 2012

March 7, 2012

Nelson Vergel, B.S.Ch.E., M.B.A.

Nelson Vergel, B.S.Ch.E., M.B.A.

In this analysis of data from the historic Women's Interagency HIV Study, HAART decreased immune activation, exhaustion, senescence, and apoptosis in CD8+ T cells (cohort mean age: 41.2 years). However, these levels did not become normalized even after a year of HAART. Therapies that reverse immune system aging used in combination with HAART may be warranted, the research suggests.

For more information, read CROI poster 331, "Impact of HAART Initiation on Immune Regulation in Aging HIV+ Women: Women's Interagency HIV Study," presented by Seema Desai.


Copyright © 2012 Remedy Health Media, LLC. All rights reserved.


Related Stories

What Did You Expect While You Were Expecting?
HIV/AIDS Resource Center for Women



This article was provided by TheBodyPRO.com. It is a part of the publication The 19th Conference on Retroviruses and Opportunistic Infections.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement